Through this engaging, continuing medical education (CME)-accredited podcast series, expert faculty delve into evidence-based strategies for utilizing biomarker testing to optimize care in hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)- metastatic breast cancer (mBC). Across five 15-minute episodes, listeners will learn about key topics such as the role of liquid biopsies, interpretation of test results, and overcoming endocrine therapy (ET) resistance. With a focus on real-world applications, the series incorporates actionable insights, multidisciplinary perspectives, and practical advice to address barriers in clinical practice. Users will gain valuable take-home messages and strategies to implement biomarker testing effectively, enhancing patient outcomes in mBC care.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://www.nexushehub.com/resources-library/biomarker-banter-hr-her2-mbc-insights/overview
- Start Date: 2025-01-15 06:00:00
- End Date: 2025-01-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: Lilly (Any division) - Amount: 96000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all